SPARQL
Downloads
Documentation/Help
Skip Header
Results
Your Query
Add common prefixes
DESCRIBE <http://purl.uniprot.org/SHA-384/8FA66678FBB94C1D860D978566C80F575B5B41F7D0D9582E7E03A4537E0F93068F7CBC2E9A508EB6543A6441954F3E9E>
Submit Query
Cancel
RDF/XML
NTriples
Turtle
Show query
Share
Subject
Predicate
Object
http://purl.uniprot.org/SHA-384/8FA66678FBB94C1D860D978566C80F575B5B41F7D0D9582E7E03A4537E0F93068F7CBC2E9A508EB6543A6441954F3E9E
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://purl.uniprot.org/core/Annotation
http://purl.uniprot.org/SHA-384/8FA66678FBB94C1D860D978566C80F575B5B41F7D0D9582E7E03A4537E0F93068F7CBC2E9A508EB6543A6441954F3E9E
http://www.w3.org/2000/01/rdf-schema#comment
"Results suggest that reduced expression level of sodium-dependent vitamin C transporter type-2 might be involved in the development of morphine side effects such as tolerance and dependency."
xsd:string
http://purl.uniprot.org/uniprot/#_7E4D8627A571F2C6080DF0DC7614192561C4E708594B19E37C11EE119C5B1F39201BB00A8D575C35C4AEE362CA772EBF
http://www.w3.org/1999/02/22-rdf-syntax-ns#subject
http://purl.uniprot.org/SHA-384/8FA66678FBB94C1D860D978566C80F575B5B41F7D0D9582E7E03A4537E0F93068F7CBC2E9A508EB6543A6441954F3E9E
http://purl.uniprot.org/uniprot/Q9WTW8
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/8FA66678FBB94C1D860D978566C80F575B5B41F7D0D9582E7E03A4537E0F93068F7CBC2E9A508EB6543A6441954F3E9E
http://purl.uniprot.org/uniprot/#_Q9WTW8-mappedCitation-19418264
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/8FA66678FBB94C1D860D978566C80F575B5B41F7D0D9582E7E03A4537E0F93068F7CBC2E9A508EB6543A6441954F3E9E